Published in J Cardiovasc Magn Reson on January 14, 2010
Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson (2013) 3.87
Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. J Cardiovasc Magn Reson (2013) 2.48
Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association. Hypertension (2015) 2.01
4D flow cardiovascular magnetic resonance consensus statement. J Cardiovasc Magn Reson (2015) 1.18
Quantification and visualization of cardiovascular 4D velocity mapping accelerated with parallel imaging or k-t BLAST: head to head comparison and validation at 1.5 T and 3 T. J Cardiovasc Magn Reson (2011) 1.15
Cardiovascular magnetic resonance artefacts. J Cardiovasc Magn Reson (2013) 1.13
Rapid pediatric cardiac assessment of flow and ventricular volume with compressed sensing parallel imaging volumetric cine phase-contrast MRI. AJR Am J Roentgenol (2012) 1.10
Heart valve disease: investigation by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 1.06
Improved cardiovascular flow quantification with time-resolved volumetric phase-contrast MRI. Pediatr Radiol (2011) 1.03
Baseline correction of phase-contrast images in congenital cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2010) 1.03
Quantification of thoracic blood flow using volumetric magnetic resonance imaging with radial velocity encoding: in vivo validation. Invest Radiol (2013) 0.99
Venous and arterial flow quantification are equally accurate and precise with parallel imaging compressed sensing 4D phase contrast MRI. J Magn Reson Imaging (2012) 0.98
Cardiac output and cardiac index measured with cardiovascular magnetic resonance in healthy subjects, elite athletes and patients with congestive heart failure. J Cardiovasc Magn Reson (2012) 0.98
Sequence optimization to reduce velocity offsets in cardiovascular magnetic resonance volume flow quantification--a multi-vendor study. J Cardiovasc Magn Reson (2011) 0.98
Four-dimensional flow assessment of pulmonary artery flow and wall shear stress in adult pulmonary arterial hypertension: results from two institutions. Magn Reson Med (2014) 0.96
Cardiovascular magnetic resonance phase contrast imaging. J Cardiovasc Magn Reson (2015) 0.96
Shared velocity encoding: a method to improve the temporal resolution of phase-contrast velocity measurements. Magn Reson Med (2011) 0.93
Inlet and outlet valve flow and regurgitant volume may be directly and reliably quantified with accelerated, volumetric phase-contrast MRI. J Magn Reson Imaging (2014) 0.93
Chemical shift-induced phase errors in phase-contrast MRI. Magn Reson Med (2012) 0.89
Analysis of temperature dependence of background phase errors in phase-contrast cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2014) 0.85
A multi-center inter-manufacturer study of the temporal stability of phase-contrast velocity mapping background offset errors. J Cardiovasc Magn Reson (2012) 0.84
Efficient and reproducible high resolution spiral myocardial phase velocity mapping of the entire cardiac cycle. J Cardiovasc Magn Reson (2013) 0.84
Assessment of global myocardial perfusion reserve using cardiovascular magnetic resonance of coronary sinus flow at 3 Tesla. J Cardiovasc Magn Reson (2014) 0.84
Automated left ventricular diastolic function evaluation from phase-contrast cardiovascular magnetic resonance and comparison with Doppler echocardiography. J Cardiovasc Magn Reson (2010) 0.83
Multi-modality image-based computational analysis of haemodynamics in aortic dissection. Biomech Model Mechanobiol (2015) 0.83
The measurement of CSF flow through the aqueduct in normal and hydrocephalic children: from where does it come, to where does it go? Childs Nerv Syst (2011) 0.83
Analysis of an automated background correction method for cardiovascular MR phase contrast imaging in children and young adults. Pediatr Radiol (2013) 0.82
Spiral tissue phase velocity mapping in a breath-hold with non-cartesian SENSE. Magn Reson Med (2013) 0.81
Towards highly accelerated Cartesian time-resolved 3D flow cardiovascular magnetic resonance in the clinical setting. J Cardiovasc Magn Reson (2014) 0.81
Pulmonary regurgitant volume is superior to fraction using background-corrected phase contrast MRI in determining the severity of regurgitation in repaired tetralogy of Fallot. Int J Cardiovasc Imaging (2015) 0.80
Clinical feasibility of a myocardial signal intensity threshold-based semi-automated cardiac magnetic resonance segmentation method. Eur Radiol (2015) 0.79
Advanced flow MRI: emerging techniques and applications. Clin Radiol (2016) 0.79
Age-specific changes in left ventricular diastolic function: a velocity-encoded magnetic resonance imaging study. Eur Radiol (2014) 0.79
Quantitating aortic regurgitation by cardiovascular magnetic resonance: significant variations due to slice location and breath holding. Eur Radiol (2015) 0.79
4D flow MRI applications for aortic disease. Magn Reson Imaging Clin N Am (2014) 0.78
Inter-study reproducibility of interleaved spiral phase velocity mapping of renal artery haemodynamics. J Cardiovasc Magn Reson (2015) 0.77
Correction to "External hydrocephalus in infants: six cases with MR venogram and flow quantification correlation". Childs Nerv Syst (2011) 0.76
Effect of protocol choice on phase contrast cardiac magnetic resonance flow measurement in the ascending aorta: breath-hold and non-breath-hold. Int J Cardiovasc Imaging (2012) 0.76
Effects of gadolinium contrast agent on aortic blood flow and myocardial strain measurements by phase-contrast cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2010) 0.76
Cardiac index after acute ST-segment elevation myocardial infarction measured with phase-contrast cardiac magnetic resonance imaging. Eur Radiol (2015) 0.76
Review of Journal of Cardiovascular Magnetic Resonance 2011. J Cardiovasc Magn Reson (2012) 0.76
In vivo and in vitro validation of aortic flow quantification by time-resolved three-dimensional velocity-encoded MRI. Int J Cardiovasc Imaging (2012) 0.75
Effects of contour propagation and background corrections in different MRI flow software packages. Acta Radiol Open (2015) 0.75
Review of journal of cardiovascular magnetic resonance 2010. J Cardiovasc Magn Reson (2011) 0.75
Comparison of 4D flow and 2D velocity-encoded phase contrast MRI sequences for the evaluation of aortic hemodynamics. Int J Cardiovasc Imaging (2016) 0.75
Method for calculating confidence intervals for phase contrast flow measurements. J Cardiovasc Magn Reson (2014) 0.75
Cardiac imaging in valvular heart disease. Br J Radiol (2011) 0.75
An innovative approach to investigate the dynamics of the cerebrospinal fluid in the prepontine cistern: A feasibility study using spatial saturation-prepared cine PC-MRI. Eur J Radiol Open (2014) 0.75
Phase-contrast MRI volume flow - a comparison of breath held and navigator based acquisitions. BMC Med Imaging (2016) 0.75
Phase Error Correction in Time-Averaged 3D Phase Contrast Magnetic Resonance Imaging of the Cerebral Vasculature. PLoS One (2016) 0.75
Stenosis of the branches of the neopulmonary artery after the arterial switch operation: A cardiac magnetic resonance imaging study. Ann Pediatr Cardiol (2013) 0.75
Three-Dimensional Volumetric Assessment of Diastolic Function by Cardiac Magnetic Resonance Imaging: The Multi-Ethnic Study of Atherosclerosis (MESA). Arq Bras Cardiol (2017) 0.75
Impact of bileaflet mitral valve prolapse on quantification of mitral regurgitation with cardiac magnetic resonance: a single-center study. J Cardiovasc Magn Reson (2017) 0.75
Concomitant gradient terms in phase contrast MR: analysis and correction. Magn Reson Med (1998) 3.51
Baseline correction of phase contrast images improves quantification of blood flow in the great vessels. J Cardiovasc Magn Reson (2007) 2.21
Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging. J Am Coll Cardiol (1994) 2.17
Blood flow imaging by cine magnetic resonance. J Comput Assist Tomogr (1986) 2.05
Magnetic resonance imaging assessment of the severity of mitral regurgitation. Comparison with invasive techniques. Circulation (1995) 1.57
Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation (1993) 1.55
Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson (2006) 1.54
Normal thoracic aorta diameter on cardiac computed tomography in healthy asymptomatic adults: impact of age and gender. Acad Radiol (2008) 1.52
Correction of phase offset errors in main pulmonary artery flow quantification. J Magn Reson Imaging (2005) 1.51
Quantification of shunt volumes in congenital heart diseases using a breath-hold MR phase contrast technique--comparison with oximetry. Int J Cardiovasc Imaging (2002) 1.14
Improved accuracy in flow mapping of congenital heart disease using stationary phantom technique. J Cardiovasc Magn Reson (2009) 1.12
Evaluation of intracardiac shunts with cardiac magnetic resonance. Curr Cardiol Rep (2005) 1.02
The effects of breath-holding on pulmonary regurgitation measured by cardiovascular magnetic resonance velocity mapping. J Cardiovasc Magn Reson (2009) 1.00
Comparison between retrospective gating and ECG triggering in magnetic resonance velocity mapping. Magn Reson Imaging (1993) 0.97
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41
Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol (2005) 5.50
Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med (2002) 5.42
MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J (2008) 4.42
Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA (2011) 4.14
Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation (2004) 3.76
Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging (2007) 3.76
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson (2013) 3.52
A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging (2003) 3.11
The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol (2008) 3.09
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging (2013) 2.89
Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol (2002) 2.87
Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation (2012) 2.71
Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity. Eur J Heart Fail (2011) 2.71
Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol (2009) 2.71
High-intensity focused ultrasound for noninvasive functional neurosurgery. Ann Neurol (2009) 2.68
Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2011) 2.66
Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol (2011) 2.66
Bicuspid aortic valve is associated with altered wall shear stress in the ascending aorta. Circ Cardiovasc Imaging (2012) 2.53
Visceral fat in hypertension: influence on insulin resistance and beta-cell function. Hypertension (2004) 2.33
On T2* magnetic resonance and cardiac iron. Circulation (2011) 2.33
EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol (2009) 2.23
Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome. Circulation (2006) 2.18
Dynamic contrast-enhanced myocardial perfusion MRI accelerated with k-t sense. Magn Reson Med (2007) 2.18
Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging (2009) 2.08
Geometric assessment of asymmetric septal hypertrophic cardiomyopathy by CMR. JACC Cardiovasc Imaging (2012) 2.07
In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke (2004) 2.06
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy. J Cardiovasc Med (Hagerstown) (2015) 2.04
Intra-abdominal adiposity and individual components of the metabolic syndrome in adolescence: sex differences and underlying mechanisms. Arch Pediatr Adolesc Med (2008) 2.02
Applications of phase-contrast flow and velocity imaging in cardiovascular MRI. Eur Radiol (2005) 1.99
Improved T2* assessment in liver iron overload by magnetic resonance imaging. Magn Reson Imaging (2008) 1.97
Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging (2003) 1.96
Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart (2013) 1.95
Regional thicknesses and thickening of compacted and trabeculated myocardial layers of the normal left ventricle studied by cardiovascular magnetic resonance. Circ Cardiovasc Imaging (2010) 1.94
Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR Registry. JACC Cardiovasc Imaging (2011) 1.93
Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease. Int J Cardiovasc Imaging (2008) 1.91
Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol (2006) 1.89
T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson (2003) 1.88
Accurate assessment of the arterial input function during high-dose myocardial perfusion cardiovascular magnetic resonance. J Magn Reson Imaging (2004) 1.86
Changes in brain morphology associated with obstructive sleep apnea. Sleep Med (2003) 1.80
An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging. BMC Med Imaging (2010) 1.80
The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol (2009) 1.76
Cardiac magnetic resonance predicts outcome in patients with premature ventricular complexes of left bundle branch block morphology. J Am Coll Cardiol (2010) 1.71
Free-breathing 3 T magnetic resonance T2-mapping of the heart. JACC Cardiovasc Imaging (2012) 1.70
Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace (2008) 1.68
Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol (2006) 1.67
Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica (2006) 1.66
Silent myocardial damage in cocaine addicts. Heart (2011) 1.65
Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology. Eur Heart J (2010) 1.65
Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function. Circulation (2013) 1.64
Prevalence of inferobasal myocardial crypts among patients referred for cardiovascular magnetic resonance. Circ Cardiovasc Imaging (2014) 1.61
Flow measurement by magnetic resonance: a unique asset worth optimising. J Cardiovasc Magn Reson (2007) 1.61
Pulmonary regurgitation: not a benign lesion. Eur Heart J (2005) 1.60
European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson (2013) 1.60
Right ventricular ischemic injury in patients with acute ST-segment elevation myocardial infarction: characterization with cardiovascular magnetic resonance. Circulation (2010) 1.60
Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification. Magn Reson Med (2008) 1.60
Motion in cardiovascular MR imaging. Radiology (2009) 1.53
Development of a novel optimized breathhold technique for myocardial T2 measurement in thalassemia. J Magn Reson Imaging (2006) 1.53
Training and accreditation in cardiovascular magnetic resonance in Europe: a position statement of the working group on cardiovascular magnetic resonance of the European Society of Cardiology. Eur Heart J (2011) 1.53
Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging (2005) 1.51
Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement and corresponding normal values. Circ Cardiovasc Imaging (2008) 1.51
Assessing normal pulse wave velocity in the proximal pulmonary arteries using transit time: a feasibility, repeatability, and observer reproducibility study by cardiovascular magnetic resonance. J Magn Reson Imaging (2007) 1.50
Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance. Arthritis Rheum (2009) 1.48
Cost-effectiveness of diagnostic strategies prior to carotid endarterectomy. Ann Neurol (2005) 1.47
Excessive right ventricular hypertrophic response in adults with the mustard procedure for transposition of the great arteries. Am J Cardiol (2002) 1.46
Coronary artery anomalies: assessment with free-breathing three-dimensional coronary MR angiography. Radiology (2003) 1.46
Prodromal angina is associated with myocardial salvage in acute ST-segment elevation myocardial infarction. Eur Heart J Cardiovasc Imaging (2013) 1.45
Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload. J Magn Reson Imaging (2006) 1.45
Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation (2005) 1.43
Black-blood T2* technique for myocardial iron measurement in thalassemia. J Magn Reson Imaging (2007) 1.41
Iron oxide particles for atheroma imaging. Arterioscler Thromb Vasc Biol (2009) 1.40
Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications. J Cardiovasc Magn Reson (2013) 1.40
Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain. Neurosurg Focus (2012) 1.40
Right ventricular remodelling in systemic hypertension: a cardiac MRI study. Heart (2011) 1.39
Myocardial T*2 measurement in iron-overloaded thalassemia: an ex vivo study to investigate optimal methods of quantification. Magn Reson Med (2008) 1.38
Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke (2006) 1.37
Multimodality cardiac imaging in the evaluation of mitral annular caseous calcification. Circulation (2011) 1.36
Stress analysis of carotid plaque rupture based on in vivo high resolution MRI. J Biomech (2005) 1.34
Emerging trends in CV flow visualization. JACC Cardiovasc Imaging (2012) 1.30
Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts. NMR Biomed (2007) 1.28
Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat. Hypertension (2008) 1.27
Volume-selective 3D turbo spin echo imaging for vascular wall imaging and distensibility measurement. J Magn Reson Imaging (2003) 1.25
Improved turbo spin-echo imaging of the heart with motion-tracking. J Magn Reson Imaging (2006) 1.25
Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology (2011) 1.23
Characterization of healing following atherosclerotic carotid plaque rupture in acutely symptomatic patients: an exploratory study using in vivo cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2011) 1.22
Variability and homogeneity of cardiovascular magnetic resonance myocardial T2-mapping in volunteers compared to patients with edema. J Cardiovasc Magn Reson (2013) 1.21
Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol (2012) 1.21
Evaluation of the efficacy of oral deferiprone in beta-thalassemia major by multislice multiecho T2*. Eur J Haematol (2006) 1.21
Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron. J Magn Reson Imaging (2009) 1.21